A new study published in Cell has unveiled a first-of-a-kind optogenetic screening platform, developed by scientists at Integrated Biosciences, a biotechnology company integrating optogenetics, ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Integrated Biosciences, a biotechnology company integrating optogenetics, chemistry and AI to discover small molecule therapeutics for age-related diseases, ...
A novel optogenetic screening platform enables control over previously intractable biological systems. Using the screening platform, scientists have been able to selectively activate the integrated ...
REDWOOD CITY, CA — July 14, 2025 — A landmark study published in Cell has unveiled a first-of-a-kind optogenetic screening platform, developed by scientists at Integrated Biosciences, a biotechnology ...
NTS serves over 1,500 facilities throughout the US, primarily in government and behavioral health end markets NTS CEO Andrew Panico will remain involved with the company to support continued growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results